BLID is a drug-responsive target of FOXO3a and multi-omics analysis reveals survival mechanisms and therapeutic vulnerabilities in BLID-deficient breast cancer cells.

Oncol Lett · 2025 · PMC12217432 · PMID 40613036

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Additionally, cell death and survival emerged as a highly significant BLID-mediated biofunction in all four breast cancer cell lines tested (MCF-7, MDA-MB-231, LCC9 and MDA-MB-468).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.